Cathie Wood Just This Biotech Bet: Reading the Signals
ARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
Find out which is better for you: cash back or reward points. Make smart financial choices that suit your lifestyle today!
27,078 articlesARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
An ETF-based approach blends residential and mortgage REITs to generate passive income without property management. A...
Webull defied flat profits with rapid top‑line growth in Q1 2026, but costs rose sharply and regulatory headwinds loo...
Meta Platforms rides a pivotal thesis: AI compute demand is real, scarce, and driving a company-wide pivot to data in...
Strive raises the dividend on SATA preferred stock to 12.75% and deploys $50 million into Strategy's STRC, while incr...
A mobile app rewards users for scrolling, propelling Mode Mobile into Deloitte’s fastest-growing software roster. Sha...
A 400-million-barrel release from strategic reserves triggered a swift market response. Oil prices eased, gasoline fu...
Quarterly filings reveal big-money moves. Seven of eight ultra-rich fund managers trimmed a single AI stock that’s su...
Micron Technology is set to release quarterly results after the bell, with investors hoping for a blowout fueled by A...
Global equities fell as AI-driven rally fizzled and investors watched for signs of a SpaceX IPO. The move underscored...
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
SpaceX begins trading on Nasdaq under SPCX, aiming to redefine public markets for space technology. Investors weigh s...